Sanofi, Regeneron’s biologic shines again in asthma trial

1st November 2017 Uncategorised 0

Regeneron and Sanofi have unveiled positive new data from a late-stage trial investigating the biologic dupilumab in adults and adolescents 12 years of age and older with severe, steroid dependent asthma.

More: Sanofi, Regeneron’s biologic shines again in asthma trial
Source: News